+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
Hyperkalemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperkalemia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 118 Pages
  • Global
From
Rickets Treatment - Global Strategic Business Report - Product Thumbnail Image

Rickets Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 181 Pages
  • Global
From
Aspergillosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 373 Pages
  • Global
From
From
From
West Nile Virus - Global Strategic Business Report - Product Thumbnail Image

West Nile Virus - Global Strategic Business Report

  • Report
  • July 2025
  • 169 Pages
  • Global
From
From
From
Restless Legs Syndrome - Global Strategic Business Report - Product Thumbnail Image

Restless Legs Syndrome - Global Strategic Business Report

  • Report
  • July 2025
  • 290 Pages
  • Global
From
From
From
Pleurodynia Treatment - Global Strategic Business Report - Product Thumbnail Image

Pleurodynia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 270 Pages
  • Global
From
Phenylketonuria Treatment - Global Strategic Business Report - Product Thumbnail Image

Phenylketonuria Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 184 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more